Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Todos Medical Inks Asian, North American Distribution Deal for Breast Cancer Tests

Todos Medical Inks Asian, North American Distribution Deal for Breast Cancer Tests

Sep 13, 2019
|
staff reporter

NEW YORK — Israeli diagnostics firm Todos Medical said today that it has signed a binding term sheet for the distribution of its TM-B1 and TM-B2 early breast cancer detection blood tests in certain Asian and North American markets.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Cancer

  1. Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC

  2. Guardant Health to Develop Liquid Biopsy Companion Diagnostic for Janssen NSCLC Therapy

  3. Amid Interest Generated by Coronavirus Testing, IPO Window Open for Dx Firms in 2020

    Premium

  4. Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.